Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

SILTUXIMAB vs SILVER SULFADIAZINE: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

SILTUXIMAB vs SILVER SULFADIAZINE: Safety Overview

Metric SILTUXIMAB SILVER SULFADIAZINE
Total FAERS Reports 472 757
Deaths Reported 89 20
Death Rate 18.9% 2.6%
Hospitalizations 145 54
Average Patient Age 47.4 yrs 57.0 yrs
% Female Patients 56.9% 58.3%
FDA Approval Date N/A Approved Prior to Jan 1, 1982
Manufacturer Recordati Rare Diseases, Inc. Ascend Laboratories, LLC
Route INTRAVENOUS TOPICAL
Marketing Status Prescription Prescription